Cargando…

N6-methyladenosine Modification of Hepatitis B Virus RNA in the Coding Region of HBx

N6-methyladenosine (m(6)A) is a post-transcriptional modification of RNA involved in transcript transport, degradation, translation, and splicing. We found that HBV RNA is modified by m(6)A predominantly in the coding region of HBx. The mutagenesis of methylation sites reduced the HBV mRNA and HBs p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Murata, Takayuki, Iwahori, Satoko, Okuno, Yusuke, Nishitsuji, Hironori, Yanagi, Yusuke, Watashi, Koichi, Wakita, Takaji, Kimura, Hiroshi, Shimotohno, Kunitada
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917364/ https://www.ncbi.nlm.nih.gov/pubmed/36768585 http://dx.doi.org/10.3390/ijms24032265

Ejemplares similares

Ubiquitination of SARS-CoV-2 NSP6 and ORF7a Facilitates NF-κB Activation
por: Nishitsuji, Hironori, et al.
Publicado: (2022)

Development of a cell-based assay to identify hepatitis B virus entry inhibitors targeting the sodium taurocholate cotransporting polypeptide
por: Miyakawa, Kei, et al.
Publicado: (2018)

Galectin-9 restricts hepatitis B virus replication via p62/SQSTM1-mediated selective autophagy of viral core proteins
por: Miyakawa, Kei, et al.
Publicado: (2022)

Engineering Cellular Biosensors with Customizable Antiviral Responses Targeting Hepatitis B Virus
por: Matsunaga, Satoko, et al.
Publicado: (2020)

Cyclophilin and Viruses: Cyclophilin as a Cofactor for Viral Infection and Possible Anti-Viral Target
por: Watashi, Koichi, et al.
Publicado: (2007)

Genome-wide CRISPR screen for HSV-1 host factors reveals PAPSS1 contributes to heparan sulfate synthesis
por: Suzuki, Takeshi, et al.
Publicado: (2022)

Identification of neutralizing epitopes in the preS2 domain of the hepatitis B virus
por: Yato, Keigo, et al.
Publicado: (2022)

Orchestration of Intracellular Circuits by G Protein-Coupled Receptor 39 for Hepatitis B Virus Proliferation
por: Goto, Kaku, et al.
Publicado: (2020)

Correction to: Required concentration index quantifies effective drug combinations against hepatitis C virus infection
por: Kakizoe, Yusuke, et al.
Publicado: (2021)

Required concentration index quantifies effective drug combinations against hepatitis C virus infection
por: Kakizoe, Yusuke, et al.
Publicado: (2021)

Human induced pluripotent stem cell-derived hepatic cell lines as a new model for host interaction with hepatitis B virus
por: Kaneko, Shun, et al.
Publicado: (2016)

EBV Exploits RNA m(6)A Modification to Promote Cell Survival and Progeny Virus Production During Lytic Cycle
por: Yanagi, Yusuke, et al.
Publicado: (2022)

NTCP and Beyond: Opening the Door to Unveil Hepatitis B Virus Entry
por: Watashi, Koichi, et al.
Publicado: (2014)

Molecular dissection of HBV evasion from restriction factor tetherin: A new perspective for antiviral cell therapy
por: Miyakawa, Kei, et al.
Publicado: (2015)

Novel reporter system to monitor early stages of the hepatitis B virus life cycle
por: Nishitsuji, Hironori, et al.
Publicado: (2015)

Investigating the hepatitis B virus life cycle using engineered reporter hepatitis B viruses
por: Nishitsuji, Hironori, et al.
Publicado: (2017)

Prolyl Isomerase Pin1 Regulates the Stability of Hepatitis B Virus Core Protein
por: Nishi, Mayuko, et al.
Publicado: (2020)

SEB genotyping: SmartAmp-Eprimer binary code genotyping for complex, highly variable targets applied to HBV
por: Delobel, Diane, et al.
Publicado: (2022)

Modulation of hepatitis B virus infection by epidermal growth factor secreted from liver sinusoidal endothelial cells
por: Chen, Shin-Wei, et al.
Publicado: (2020)

Role of Epstein–Barr Virus C Promoter Deletion in Diffuse Large B Cell Lymphoma
por: Mabuchi, Seiyo, et al.
Publicado: (2021)

Hepatitis C virus utilizes lipid droplet for production of infectious virus
por: Ogawa, Kazuya, et al.
Publicado: (2009)

Amino Acid Polymorphism in Hepatitis B Virus Associated With Functional Cure
por: Honda, Takashi, et al.
Publicado: (2021)

5′-O-Masked 2′-deoxyadenosine analogues as lead compounds for hepatitis C virus (HCV) therapeutic agents
por: Ikejiri, Masahiro, et al.
Publicado: (2007)

Regulation of Epstein-Barr Virus Life Cycle and Cell Proliferation by Histone H3K27 Methyltransferase EZH2 in Akata Cells
por: Ichikawa, Takaya, et al.
Publicado: (2018)

Deletion of Viral microRNAs in the Oncogenesis of Epstein–Barr Virus-Associated Lymphoma
por: Kimura, Hiroshi, et al.
Publicado: (2021)

Signal Peptidase Complex Subunit 1 Participates in the Assembly of Hepatitis C Virus through an Interaction with E2 and NS2
por: Suzuki, Ryosuke, et al.
Publicado: (2013)

Molecular Basis of Epstein–Barr Virus Latency Establishment and Lytic Reactivation
por: Murata, Takayuki, et al.
Publicado: (2021)

Development of Mouse Hepatocyte Lines Permissive for Hepatitis C Virus (HCV)
por: Aly, Hussein Hassan, et al.
Publicado: (2011)

Epstein-Barr Virus BBRF2 Is Required for Maximum Infectivity
por: Masud, H. M. Abdullah Al, et al.
Publicado: (2019)

Should a viral genome stay in the host cell or leave? A quantitative dynamics study of how hepatitis C virus deals with this dilemma
por: Iwanami, Shoya, et al.
Publicado: (2020)

Mechanism of HBx carcinogenesis interaction with non-coding RNA in hepatocellular carcinoma
por: Wang, Zhuoran, et al.
Publicado: (2023)

Multiple antiviral activities of the antimalarial and anti-hepatitis C drug candidates N-89 and N-251
por: Ueda, Youki, et al.
Publicado: (2018)

Distribution Patterns of DNA N6-Methyladenosine Modification in Non-coding RNA Genes
por: Li, Yu, et al.
Publicado: (2020)

Ick Suppresses Gene Expression from Various Promoters Including Human T‐Cell Leukemia Virus Type I Promoter
por: Ohta, Masataka, et al.
Publicado: (1990)

Initial Characterization of the Epstein–Barr Virus BSRF1 Gene Product
por: Yanagi, Yusuke, et al.
Publicado: (2019)

Serine 13 of the human cytomegalovirus viral cyclin-dependent kinase UL97 is required for regulatory protein 14-3-3 binding and UL97 stability
por: Iwahori, Satoko, et al.
Publicado: (2022)

Epigenetic reprogramming promotes the antiviral action of IFNα in HBV-infected cells
por: Gailhouste, Luc, et al.
Publicado: (2021)

Corrigendum: Distribution Patterns of DNA N6-Methyladenosine Modification in Non-coding RNA Genes
por: Li, Yu, et al.
Publicado: (2020)

The Interaction Between N(6)-Methyladenosine Modification and Non-Coding RNAs in Gastrointestinal Tract Cancers
por: Yao, Lin, et al.
Publicado: (2022)

Non-coding RNA and n6-methyladenosine modification play crucial roles in neuropathic pain
por: Zhang, Kexin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ii8le7et22t401a5i4a81avdjr